Showing results (2091-2100 of 3,020) with videos related to

Sort By:
Pageof 302
European Heart Journal|October 9, 2010
Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patientsGerhard-Paul Diller, Alessandro Giardini, Konstantinos Dimopoulos, et al.
International Journal of Cardiology|March 23, 2010
Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapyEdgar L W Tay, Maria Papaphylactou, Gerhard Paul Diller, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|October 2, 2024
Central versus peripheral VA ECMO for cardiogenic shock: an 8-year experience of a tertiary cardiac surgery center in GreeceMichael Antonopoulos, Antigone Koliopoulou, Dimitrios Elaiopoulos, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 31, 2009
Effects of dobutamine on gut mucosal nitric oxide production during endotoxic shock in rabbitsSuzana M Lobo, Francisco G Soriano, Denise F Barbeiro, et al.
International Journal of Cancer|January 17, 2019
Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myelomaEvangelos Terpos, Eirini Katodritou, Argiris Symeonidis, et al.
Leukemia & Lymphoma|September 23, 2017
Carfilzomib-dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ENDEAVOR studyHartmut Goldschmidt, Philippe Moreau, Heinz Ludwig, et al.
Medicina (Kaunas, Lithuania)|November 27, 2025
Thermal Ablation as a Non-Surgical Alternative for Thyroid Nodules: A Review of Current EvidenceAndreas Antzoulas, Vasiliki Garantzioti, George S Papadopoulos, et al.
Journal of Cardiovascular Development and Disease|February 23, 2024
Advanced Heart Failure: Therapeutic Options and Challenges in the Evolving Field of Left Ventricular Assist DevicesMichael Antonopoulos, Michael J Bonios, Stavros Dimopoulos, et al.
Expert Review of Anticancer Therapy|June 9, 2015
Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myelomaPaul G Richardson, Jacob P Laubach, Sagar Lonial, et al.
American Journal of Hematology|January 13, 2015
Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategiesEfstathios Kastritis, Maria Roussou, Maria Gavriatopoulou, et al.
Pageof 302